Protective effects of luteolin against amyloid beta-induced oxidative stress and mitochondrial impairments through peroxisome proliferator-activated receptor γ-dependent mechanism in Alzheimer's disease
Authors:
Top Cited Papers
Open Access
- 12 August 2023
- journal article
- research article
- Published by Elsevier in Redox Biology
- Vol. 66, 102848
Abstract
No abstract availableKeywords
Funding Information
- Shenzhen University
This publication has 81 references indexed in Scilit:
- Why size matters – balancing mitochondrial dynamics in Alzheimer's diseaseTrends in Neurosciences, 2013
- Peroxisome Proliferator-Activated Receptor (PPAR) γ and PPARα Agonists Modulate Mitochondrial Fusion-Fission Dynamics: Relevance to Reactive Oxygen Species (ROS)-Related Neurodegenerative Disorders?PLOS ONE, 2013
- Mitochondrial Fission, Fusion, and StressScience, 2012
- From Mitochondrial Dysfunction to Amyloid Beta Formation: Novel Insights into the Pathogenesis of Alzheimer’s DiseaseMolecular Neurobiology, 2012
- PPARgamma rescue of the mitochondrial dysfunction in Huntington's diseaseNeurobiology of Disease, 2012
- Partial Agonists Activate PPARγ Using a Helix 12 Independent MechanismStructure, 2007
- Mitochondrial dysfunction and oxidative stress in neurodegenerative diseasesNature, 2006
- Clearance of Alzheimer's Aβ PeptideNeuron, 2004
- Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's diseaseHuman Molecular Genetics, 2004
- Resistance to cerebral ischemic injury in UCP2 knockout mice: evidence for a role of UCP2 as a regulator of mitochondrial glutathione levelsJournal of Neurochemistry, 2004